Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Top Stories > Acquisition of 70.80% Stake in Miljon Medi APP

Acquisition of 70.80% Stake in Miljon Medi APP

Published by Gbaf News

Posted on June 15, 2018

3 min read

Last updated: January 21, 2026

Rouble value stability analysis in relation to US dollar trends - Global Banking & Finance Review — The image illustrates the rouble's steady performance near 60 against the dollar, reflecting market trends amidst stock index declines. It captures key financial indicators relevant to the Russian economy.

MUMBAI-GlobalSpace Technologies Limited (BSE: 540654), a fast growing new-age technology company, today announced the acquisition of 70.80% stake in Miljon Medi APP for an undisclosed sum.

Miljon Medi APP is a health tech startup with B2B Digital Platform (‘Platform’) that connects generics pharmaceutical manufacturers to the entire pharma channel till retail chemist. The company claims to have some of the leading generics manufacturers already on the platform with an existing network of around 73 distributors and 9380 chemists as its active users. The company’s vision is to enable quality and certified generics reach the last mile so as to benefit the patients.

For GlobalSpace, it’s a strategic acquisition that would further consolidate its vision of creating a truly integrated digital healthcare ecosystem. The company has thought leadership in building a digital platform for pharma sales force and doctors.

Commenting on the transaction, Mr. Krishna Singh, MD, GlobalSpace, said, “This is a synergistic acquisition for us, we have already built an evolved digital platform for pharma distribution, including ERP, Mobile and Web app, it would provide the much-needed technical scalability and viability to Miljon Medi APP. Merging GlobalSpace’s tech platform with Miljon’s existing network would surely provide us the initial impetus to grow this platform to be India’s largest Pharma channel network.”

MUMBAI-GlobalSpace Technologies Limited (BSE: 540654), a fast growing new-age technology company, today announced the acquisition of 70.80% stake in Miljon Medi APP for an undisclosed sum.

Miljon Medi APP is a health tech startup with B2B Digital Platform (‘Platform’) that connects generics pharmaceutical manufacturers to the entire pharma channel till retail chemist. The company claims to have some of the leading generics manufacturers already on the platform with an existing network of around 73 distributors and 9380 chemists as its active users. The company’s vision is to enable quality and certified generics reach the last mile so as to benefit the patients.

For GlobalSpace, it’s a strategic acquisition that would further consolidate its vision of creating a truly integrated digital healthcare ecosystem. The company has thought leadership in building a digital platform for pharma sales force and doctors.

Commenting on the transaction, Mr. Krishna Singh, MD, GlobalSpace, said, “This is a synergistic acquisition for us, we have already built an evolved digital platform for pharma distribution, including ERP, Mobile and Web app, it would provide the much-needed technical scalability and viability to Miljon Medi APP. Merging GlobalSpace’s tech platform with Miljon’s existing network would surely provide us the initial impetus to grow this platform to be India’s largest Pharma channel network.”